S-1/A: Hinge Health Files for IPO, Aiming to Revolutionize Musculoskeletal Care

Sentiment:

S-1/A Filing


Hinge Health, a technology-driven healthcare company focused on musculoskeletal (MSK) care, has filed an S-1/A form indicating its intent to go public, seeking to transform outcomes, experience, and costs in the healthcare system.

Capital raiseHinge Health is offering shares of its Class A common stock in an initial public offering.The initial public offering price per share of Class A common stock is expected to be between $ and $.The company intends to use a portion of the net proceeds from this offering to satisfy tax withholding and remittance obligations related to the RSU Net Settlement.The company currently intends to use the remaining net proceeds of this offering primarily for general corporate purposes, working capital, and to fund its growth strategies and initiatives discussed in this prospectus.The company may also use a portion of the net proceeds to acquire or invest in complementary businesses, products, services, technologies, or other assets.
Better than expectedThe company's revenue growth rate increased from 33% in 2024 to 50% in Q1 2025.The company achieved a gross margin of 81% in Q1 2025, compared to 70% in Q1 2024.The company had net income of $17.1 million in Q1 2025, compared to a net loss of $26.5 million in Q1 2024.

Summary

  • Hinge Health, Inc. has filed an amended S-1 registration statement for its initial public offering.
  • The company aims to transform musculoskeletal care using technology to improve outcomes and reduce costs.
  • Hinge Health's platform provides personalized MSK care through AI-powered motion tracking and a wearable device, monitored by a care team.
  • The company reported $390.4 million in revenue for 2024, a 33% year-over-year increase, and $123.8 million for the three months ended March 31, 2025, a 50% year-over-year increase.
  • Hinge Health's platform has demonstrated a 68% average improvement in pain and a 58% reduction in depression and anxiety among participants.
  • The company's clients include 49% of Fortune 100 companies and 42% of Fortune 500 companies.
  • Hinge Health intends to list its Class A common stock on the New York Stock Exchange under the symbol HNGE.
  • The company will have a dual-class structure, with Class B shares having 15 votes each and Class A shares having one vote each.
  • Tiger Global will initially hold the Series E preferred stock, retaining certain rights that could impact the value of Class A common stock.
  • The company plans to use the IPO proceeds for general corporate purposes and potential acquisitions.

Sentiment

Score: 8

Explanation: The document presents a positive outlook for Hinge Health, highlighting its strong financial performance, innovative platform, and large market opportunity. While there are some risks mentioned, the overall tone is optimistic and suggests a promising future for the company.

Positives

  • Hinge Health is experiencing rapid revenue growth, with a 33% increase in 2024.
  • The company's platform has demonstrated significant improvements in pain and mental health for its users.
  • Hinge Health has a strong client base, including a significant portion of Fortune 100 and 500 companies.
  • The company has a high client retention rate of 98%.
  • Hinge Health's technology-driven approach allows for scalable and efficient care delivery.
  • The company has a strong partner network, including major health plans and PBMs.
  • Hinge Health has a high client satisfaction score (NPS of 87).

Negatives

  • The company has a history of net losses, although the net loss was significantly reduced in 2024.
  • The company will have a dual-class stock structure, which concentrates voting control.
  • Tiger Global will initially hold the Series E preferred stock, retaining certain rights that could impact the value of Class A common stock.

Risks

  • The company may not be able to achieve or maintain profitability.
  • The company's growth initiatives may not be successful.
  • The company operates in a competitive industry.
  • The company's increasing reliance on AI and machine learning technologies may expose it to significant risks.
  • The company may be unable to protect its intellectual property.
  • The company is subject to extensive government regulation.
  • The price of the company's Class A common stock may be volatile.
  • The dual class structure of the company's common stock will have the effect of concentrating voting control with the holders of the company's Class B common stock, including Daniel Perez and Gabriel Mecklenburg (the company's Founders), and the holders of the company's Series E preferred stock, who will collectively hold in the aggregate % of the voting power of the company's capital stock following the completion of this offering.

Future Outlook

Hinge Health intends to continue expanding its client base, increasing adoption across its existing client base, launching new programs, and expanding into new markets, including international expansion.

Management Comments

  • Our vision is to build a new health system that transforms outcomes, experiences and costs by using technology to scale and automate the delivery of care.
  • We have a century of work aheadI hope youll join us on this journey.
  • We seek to be the best solution on the market, the most validated solution on the market, and the easiest to buy.

Industry Context

The announcement comes amid a growing trend of digital health companies seeking to address the rising costs and inefficiencies in the healthcare system, particularly in the musculoskeletal care market.

Comparison to Industry Standards

  • Hinge Health competes with other digital MSK platforms such as Kaia Health, Omada Health, Sword Health, and Vori Health.
  • The company's reported 77% gross margin for 2024 is significantly higher than traditional in-person physical therapy.
  • Hinge Health's 2.4x ROI for clients is a key metric used to attract and retain customers, and is a common benchmark in the digital health industry.
  • The company's 98% client retention rate is a strong indicator of customer satisfaction and the effectiveness of its platform.

Related Party Transactions

  • The document mentions a stock repurchase agreement with Coatue, a holder of more than 5% of the company's outstanding capital stock.
  • The document mentions that a sibling of Daniel Perez, the company's Chief Executive Officer and Director, is a partner with Perkins Coie LLP, a law firm that the company engages for legal services.
  • The document mentions that Daniel Perez and Gabriel Mecklenburg, the company's Founders, transferred shares of common stock to family trusts for estate planning purposes and for no consideration.

Stakeholder Impact

  • Shareholders: The IPO will provide liquidity for existing shareholders and allow them to participate in the company's future growth.
  • Employees: The company's success will create opportunities for career advancement and potential equity appreciation.
  • Customers: The company's innovative platform will provide access to more effective and affordable musculoskeletal care.
  • Suppliers: The company's growth will increase demand for their products and services.
  • Creditors: The company's strong financial position will ensure its ability to meet its debt obligations.

Next Steps

  • The company will proceed with its initial public offering.
  • The company will continue to expand its client base and launch new programs.
  • The company will continue to invest in its technology platform and AI capabilities.
  • The company will explore potential acquisitions and strategic partnerships.

Key Dates

DateDescription
January 2012Hinge Health originally established as Marblar Limited.
March 2016Hinge Health, Inc. incorporated as a Delaware corporation.
April 2016Marblar Limited and Hinge Health, Inc. entered into a Share Exchange Agreement.
2016Launched first U.S. client.
2024Began introducing global program to clients that are United States-based multinational corporations and expanded into Canada.
First half 2025Expect to offer global program in several European countries.
May 5, 2025Date of S-1/A filing.
, 2025Expected date of delivery of Class A common stock to purchasers.

Keywords

Hinge Health, musculoskeletal care, MSK, digital health, IPO, initial public offering, AI, artificial intelligence, telehealth, virtual care, healthcare, investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.